trending Market Intelligence /marketintelligence/en/news-insights/trending/D_zJB2Tvku7fYH1GUWSPsQ2 content esgSubNav
In This List

Editas Medicine director resigns

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Editas Medicine director resigns

Douglas Cole resigned as director of Editas Medicine Inc., effective Dec. 21.

Cole's decision to resign did not result from any disagreement with the company on any matter relating to the company's operations, policies or practices.